|
Market Closed -
NSE India S.E.
07:05:08 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 2,300.00 INR | +1.51% |
|
+4.83% | +13.01% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
Stock exchange
NSE India S.E.
GLENMARK 2,300.00 ₹
+1.51%
1.05B
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLENMARK | 2,300.00INR | +1.51% | 1.05B ₹ | ||
Bombay S.E.
| GLENMARK | 2,300.35INR | +1.39% | 38.02M ₹ |
Quotes 5-day view: Glenmark Pharmaceuticals Limited
Delayed Quote NSE India S.E.
| 2026-10-22 | 2026-10-23 | 2026-10-26 | 2026-10-27 | 2026-10-28 | |
|---|---|---|---|---|---|
| Last | ₹2,198.50 | ₹2,166.60 | ₹2,225.80 | ₹2,265.70 | ₹2,300.00 |
| Volume | 576,619 | 892,797 | 969,672 | 483,378 | 455,830 |
| Change | +0.20% | -1.45% | +2.73% | +1.79% | +1.51% |
| Opening | ₹2,168.00 | ₹2,196.00 | ₹2,135.60 | ₹2,214.70 | ₹2,268.00 |
| High | ₹2,218.80 | ₹2,203.80 | ₹2,229.00 | ₹2,275.00 | ₹2,318.00 |
| Low | ₹2,160.30 | ₹2,101.60 | ₹2,133.00 | ₹2,214.60 | ₹2,261.90 |
Performance
| 1 day | +1.51% | ||
| 1 week | +4.83% | ||
| Current month | -1.49% | ||
| 1 month | -1.11% | ||
| 3 months | +5.28% | ||
| 6 months | -4.31% | ||
| Current year | +13.01% | ||
| 1 year | +26.71% | ||
| 3 years | +209.49% | ||
| 5 years | +365.12% | ||
| 10 years | +146.50% |
Volumes
marketsDaily volume
455,830
Estimated daily volume
455,830
Avg. Volume 20 sessions
564,668
Daily volume ratio
0.81
Avg. Volume 20 sessions INR
1,298,736,400
Avg. Volume 20 sessions USD
13,640,628.41
Record volume 1
89,266,590
Record volume 2
65,123,680
Record volume 3
39,631,540
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (INR)
641,102,243,000
Market Cap (USD)
6,731,389,448
Net sales (INR)
169,825,110,000
Net sales (USD)
1,783,114,887
Number of employees
16,946
Sales / Employee (INR)
10,021,545
Sales / Employee (USD)
105,223
Free-Float
51.04%
Free-Float capitalization (INR)
327,256,492,186
Free-Float capitalization (USD)
3,436,099,191
Average Daily Capital Traded
0.2%
Indicators
Moving average 5 days
2,210.14
Moving average 20 days
2,272.66
Moving average 50 days
2,355.82
Moving average 100 days
2,286.97
Price spread / (MMA5)
-3.91%
Price spread / (MMA20)
-1.19%
Price spread / (MMA50)
+2.43%
Price spread / (MMA100)
-0.57%
STIM
RSI 9 days
43.97
RSI 14 days
42.85
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.51% | +4.83% | +26.71% | +209.49% | 6.73B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.29% | +1.01% | +39.25% | +89.71% | 403.43B | |
| Weighted average by Cap. | +0.26% | +0.71% | +44.47% | +89.22% |
Historical Quotes: Glenmark Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
704ab22461.6V5qrVrC8HrMrYvQNPBla29M2GgDLnchhuvy_nxtyuk.sTAolBL2uhKg-viIVsEJJRkTlD1gGABP1KOdyi4J8qSrblrOLp2EKpr97A
| Date | Price | Volume | Total |
|---|---|---|---|
| 06:23:04 | 2,300.00 | 80 | 450,112 |
| 06:21:55 | 2,300.00 | 1 | 450,032 |
| 06:21:30 | 2,300.00 | 1 | 450,031 |
| 05:44:57 | 2,300.00 | 149 | 450,030 |
| 05:44:50 | 2,300.00 | 20 | 449,881 |
| 05:44:44 | 2,300.00 | 221 | 449,861 |
| 05:44:37 | 2,284.60 | 613 | 449,640 |
| 05:44:30 | 2,292.50 | 98 | 449,027 |
Price Extremes
| 1 week | 2,101.6 |  | 2,318 |
| 1 month | 2,101.6 | | 2,410 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,801.4 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
Monthly variations
Annual variations
| 2026 | +13.01% | ||
| 2025 | +26.48% | ||
| 2024 | +88.43% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Stocks
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
